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ABSTRACT
Tumor progression depends on the tumor-stroma interaction. In the breast, 
adipose tissue is the predominant stromal type. We have previously demonstrated 
that conditioned media (CMs) from explants of human adipose tissue of tumor breasts 
(hATT) increase proliferation and migration of breast cancer epithelial cells when 
compared to human adipose tissue from normal breasts (hATN). In this work, we aim 
to identify specific proteins and molecular/biological pathways associated with the 
secretion profile of hATT and hATN explants.
hATT-CMs and hATN-CMs were separated by SDS-PAGE and analyzed by means 
of two-dimensional nano-liquid chromatography-mass spectrometry. The data was 
analyzed using ProteoIQ and FunRich software. In addition, 42 cytokines from hATT-
CMs and hATN-CMs were assayed by a protein antibody assay. Compared to hATN-
CMs, hATT-CMs showed greater protein diversity. We found that hATT-CMs presented 
a greater amount of proteins related to complement system activity, metabolism and 
immune system, as well as proteins involved in a variety of biological processes such 
as signal transduction and cell communication. Specifically, apolipoprotein AI and AII, 
complement component 3, and vimentin and desmin were significantly increased in 
hATT-CMs versus hATN-CMs. Moreover, a multivariate discriminant analysis of the 
cytokines detected by the array showed that IL-6, MCP-2 and GRO cytokines were 
sufficient and necessary to differentiate hATT-CMs from hATN-CMs. This analysis also 
showed that the levels of these three cytokines, taken together, correlated with stage 
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and histological grade of the tumor in the hATT-CMs group, and with body mass index 
in the hATN-CMs group.
INTRODUCTION
An essential information exchange is established 
between epithelial tissue and fibroblastic/adipose 
stroma during normal morphogenesis and functionality 
of the breast, as well as in cancer development. 
A deep understanding of this epithelial-stromal 
interaction could help to unravel new pathways and 
processes involved in tumor progression. Tumor 
microenvironment is one of the emerging topics of 
interest among oncology researchers [1–5]. Interactions 
of tumor cells with fibroblasts, immune cells and 
endothelial cells have been subject of extensive studies 
in different types of cancer, including breast, prostate 
and melanoma [6–9]. However, adipocytes and adipose 
tissue have recently started to gain attention as a key 
component of the tumor stroma [10–13]. Adipose tissue 
is a bioactive endocrine organ that secretes soluble 
factors and contributes significantly to the composition 
of the extracellular matrix (ECM). Adipocytes can 
influence tumor progression through the secretion of 
lipids, adipokines, cytokines and hormone conversion 
mediated by aromatases [14–16]. We have recently 
shown that conditioned media (CMs) from explants 
of human adipose tissue from tumor breasts (hATT) 
increase the proliferation and migration of breast cancer 
epithelial cell lines, as opposed to CMs from explants 
of adipose tissue from normal breasts (hATN) [17]. 
We also demonstrated that adipocytes from the tumor 
microenvironment show a less differentiated state 
than adipocytes from a normal microenvironment. 
This would indicate a loss of normal functions of 
adipocytes (such as energy storage), and the acquisition 
of others that might favor tumor growth [18]. Some 
groups have studied the secretome from tumor breast 
adipose tissue and interstitial fluid from fresh adipose 
tissue from cancer patients [19, 20]. However, in both 
cases, the breast adipose tissue was only from a tumor 
microenvironment origin. The comparison if this 
secretome with one from breast adipose tissue of healthy 
women remains pending. In the present work, we aim to 
characterize proteins and molecular/biological processes 
and pathways associated with differences between CMs 
of human adipose tissue from normal (hATN) and tumor 
(hATT) breasts. We performed, to our knowledge, 
the first proteomic analysis which compares breast 
adipose tissue from healthy women with that of a tumor 
microenvironment from cancer patients.
The identification of factors that are differentially 
secreted by normal and tumor breast adipose tissue, and 
the study of their possible involvement in the regulation 
of tumor progression, might help develop new strategies 
to prevent/detect and/or treat breast cancer.
RESULTS
hATT-CMs have greater protein diversity than 
hATN-CMs
To begin with the identification and characterization 
of the different set of proteins present in the CMs, we 
separated the proteins of hATT-CMs and hATN-CMs in 
large polyacrylamide gels. In these gels, we observed that 
hATT-CMs present a greater number of bands compared 
to hATN-CMs (Figure 1A), indicating a greater protein 
diversity. Furthermore, aliquots from the same CMs 
were analyzed by means of two-dimensional nano-liquid 
chromatography-mass spectrometry (2D-nanoLC-MS/MS) 
with the aim of identifying specific proteins. The in silico 
analysis of the data was performed with ProteoIQ and 
FunRich software. Interestingly, the analysis confirmed 
that hATT-CMs present higher protein diversity than 
hATN-CMs and also revealed that only 22.7% of the 
proteins detected in hATT-CMs are common with hATN-
CMs (Figure 1B). In addition, the results showed that 
97.5% in hATT-CMs and 100% in hATN-CMs of the total 
proteins identified are normally found in plasma, which 
confirms that the CMs are mostly composed of secreted 
or extracellular factors (the full set of proteins detected 
are listed in Supplementary Table 1 for hATT-CMs and 
Supplementary Table 2 for hATN-CMs).
Biological processes and pathways associated 
with differences between hATT-CMs and hATN-
CMs
An overall analysis of the processes and pathways 
represented in the different CMs showed that proteins 
in both, hATN-CMs and hATT-CMs, were assigned 
to processes such as cell growth and/or maintenance, 
metabolism, cell communication, transport and signal 
transduction (data not show). Furthermore, a comparison 
between the processes represented in the hATT-CMs 
versus the hATN-CMs revealed that hATT-CMs 
expressed more proteins related to immune response, 
peptide and aldehyde metabolism and cell communication 
(Figure 2A). In addition, we found that hATT-CMs 
were enriched in proteins related to complement system 
activity, metabolism, membrane trafficking and epithelial-
to-mesenchymal transition, among others. On the other 
hand, hATT-CMs had lesser amount of proteins related to 
mesenchymal-to-epithelial transition and white adipocyte 
differentiation pathways (Figure 2B).
Furthermore, several different proteins were found 
overrepresented in hATT-CMs versus hATN-CMs. Among 
these, a set of apolipoproteins, which are proteins involved 
in lipid transport and metabolism, were overexpressed 
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in hATT-CMs compared to hATN-CMs (Figure 2C). 
Particularly, we found overexpressed apolipoprotein AI 
and AII (20-fold and 13.5-fold change) which are involved 
in lipid metabolic processes and apolipoprotein D (1.5-
fold change), marker for senescent cells. In addition, 
hATT-CMs were also enriched in complement component 
3 (C3) (20-fold change), involved in the activation of the 
complement system, and in vimentin and desmin (8.5-fold 
and 6.5 fold change), which are mesenchymal cell proteins 
related to an invasive breast cancer phenotype.
Therefore, we confirm that the adipose tissue 
surrounding the tumor would stimulate tumor progression 
by secreting pro-tumorigenic factors.
IL-6, GRO and MCP-2 are necessary and 
sufficient to differentiate hATT-CMs from 
hATN-CMs
To complete the proteomics analysis, we used an 
antibody array to test 6 hATT-CMs and 5 hATN-CMs 
against 42 specific cytokines. We found that IL-6, IL-
8, MCP-1 (CCL2), GRO (alpha, beta and/or gamma) 
and angiogenin presented the higher levels from the 42 
cytokines evaluated both in hATT-CMs and hATN-CMs 
(Figure 3A and Supplementary Figure 1). MCP-2 (CCL8), 
and RANTES (CCL5) were also found in at least one of the 
CMs. The univariate analysis for each of these cytokines 
showed that IL-6 tended to be increased in hATT-CMs 
versus hATN-CMs. Interestingly, the opposite was found 
with MCP-1 and MCP-2, which showed a tendency to be 
decreased in the hATT-CMs when compared to the hATN-
CMs (Figure 3B). We did not find a significant difference 
between these cytokines, however this could be due to the 
small number of samples tested and because of the number 
of variables that are being tested at the same time. Taken 
this into consideration, we next tested the relevance of these 
cytokines by evaluating if some of them could be sufficient 
to differentiate the group of hATT-CMs from hATN-CMs. 
For this, we performed a multivariate discriminant analysis 
starting with the 7 cytokines listed above. The multivariate 
Figure 1: Comparison of protein composition and diversity of hATT-CMs and hATN-CMs. (A) Proteins present in 100 μl 
of hATT-CM (n=7) and hATN-CMs (n=3) were separated in a SDS-polyacrylamide gel dyed with Coommassie Brilliant Blue. hATT-CMs: 
samples 2, 9, 8, 7, 5*, 11 and 10 (Sample 5* was excluded from further analysis because it belongs to a male breast cancer patient). hATN-
CMs: samples I, F and O. CTL: control-CM. MK: molecular weight markers. (B) Aliquots of 30 μg of the same CMs were analyzed by 
2D-nanoLC-MS/MS. Venn diagram showing unique and common proteins between hATN-CMs (n=3) and hATT-CMs (n=3).
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analysis showed that IL6, GRO (alpha, beta and/or gamma) 
and MCP-2 were necessary and sufficient to differentiate 
hATT-CMs from hATN-CMs (Figure 3C). Surprisingly, we 
found that the score assigned to each CM, which comprises 
the levels of these cytokines taken together, significantly 
correlated with tumor stage and histological grade (HG) of 
hATT-CMs (Table 1) and with body mass index (BMI) of 
hATN-CMs (Table 2) (p<0.05).
DISCUSSION
Epithelial-stromal interactions mediate the 
development and progression of breast cancer. Adipocytes 
are the predominant stromal cell type in breast tissue. We 
have recently demonstrated that breast adipose tissue from 
a tumor microenvironment, through the release of soluble 
factors, can influence the behavior of breast cancer cells 
Figure 2: Analysis of biological processes/pathways present in the secretome of hATN and hATT. Relative expression 
difference in specific proteins. In silico analysis of data from 2D-nano-LC-MS/MS of hATN-CMs (n=3) and hATT-CMs (n=3). (A) Column 
chart representing fold change in biological processes present in hATT-CMs relative to hATN-CMs. (B) Bar chart representing fold change 
in biological pathways present in hATT-CMs relative to hATN-CMs. (C) Proteins in hATT-CMs (n=3) and hATN-CMs (n=3) were identified 
by 2D-nano-LC-MS/MS and relative changes in the presence of the identified proteins were analyzed. Dot blot represents relative changes 
of each protein (Protein ID) in hATT-CMs compared to hATN-CMs. Key proteins are marked.
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Figure 3: IL-6, MCP-2 and GRO as key cytokines that differentiate the secretome of hATT from hATN. hATT-CMs 
(n=6) and hATN-CMs (n=5) were assessed against a 42 Cytokines Antibody Array. (A) Representative images of a membrane incubated 
with 1mL of hATN-CM or hATT-CM. Rectangles mark relevant cytokines. (B) Univariate analysis comparing the levels of IL-6, IL-8, 
MCP-1, MCP-2, GRO, angiogenin and RANTES from the array between hATN-CMs and hATT-CMs. Scatter plot shows mean ± SEM. 
a.u.: arbitrary units. Even though no significant difference was found, a tendency was seen in IL-6, MCP-1 and MCP-2. (C) A Multivariate 
Discriminant Analysis of the cytokines from (B)showed that IL-6, MCP-2 and GRO were sufficient and necessary to differentiate hATT-
CMs from hATN-CMs. Score: score assigned to each CM from the discriminant analysis. A more positive score represents higher levels of 
MCP-2 and GRO and lower levels of IL-6.
[17, 18]. The present work aims to further characterize this 
bidirectional communication by identifying and comparing 
the secretome of human adipose tissue explants from 
normal (hATN) and tumor (hATT) breasts. Therefore, we 
performed, to our knowledge, the first proteomic analysis 
comparing human adipose tissue from normal and tumor 
breasts.
Nowadays, large-scale proteomics techniques allow 
identifying and comparing the protein composition of 
extremely complex protein samples. Therefore, in order 
to analyze and compare secretion profiles from hATT and 
hATN, we performed a proteomics study of hATT-CMs 
and hATN-CMs. On the one hand, we found that almost 
all proteins detected in hATT-CMs and hATN-CMs are 
intrinsic to plasma/serum. Thus, these proteins can be 
normally found as extracellular components.
In addition, we found that hATT-CMs present 
an increased protein diversity compared to hATN-
CMs. This result was obtained by protein separation in 
polyacrylamide gels and 2D-nanoLC-MS/MS analysis 
(Figure 1A). Furthermore, hATN-CMs samples showed a 
very similar secretion profile between them, while hATT-
CMs samples showed higher diversity. This result agrees 
with what we found when employing the CMs in different 
functional assays, as shown in our previous work [18].
Furthermore, the comparison of the proteomic 
profiles between hATT-CMs and hATN-CMs showed that 
some biological processes and pathways are increased in 
hATT-CMs compared to hATN-CMs (such as immune 
response and several metabolic pathways, Figure 2A-
2B). C3 from the complement system was one of the 
proteins detected involved in the immune response 
[21], and its activation is associated with an increase in 
local inflammation. Several works have found a relation 
between local inflammation and the presence of a tumor 
[22, 23]. In fact, inflammation of tumor microenvironment 
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has been shown to induce a “reactive” tumor stroma, were 
events like proliferation, invasion and metastasis are 
stimulated [24].
We also found that hATT-CMs present increased 
levels of several proteins involved in lipid metabolism 
and transport such as apolipoproteins AI and AII (Figure 
2C). All apolipoproteins can transport lipids, including 
fatty acids (FAs) [25]. In fact, there is evidence that in this 
way adipocytes may release triglycerides and FAs, that are 
then taken as energy source by nearby tumor cells [26, 
27]. Furthermore, Wang et al., using an in vitro co-culture 
system, recently demonstrated that a metabolic symbiosis 
occurs between adipocytes and breast cancer tumor cells 
[12]. Our present results are therefore in accordance with 
previous works, suggesting that adipose tissue from tumor 
microenvironment could be “feeding” tumor cells through 
the release of lipids.
In addition, the comparative analysis of the data 
obtained from 2D-nanoLC-MS/MS showed increased 
levels of vimentin and desmin in hATT-CMs compared 
to hATN-CMs (Figure 2C). These two proteins are part 
of the intermediate filaments of the cytoskeleton and 
are also markers for mesenchymal cells [28]. Vimentin 
overexpression has been found in several cancer cells, 
including breast cancer, and this overexpression has 
been associated to an increase in cell invasion and 
tumor growth [29]. Although the role of vimentin as an 
extracellular component is not yet clear, it has been found 
to be a component of adipose tissue secretome in several 
works [20, 30]. Furthermore, some groups have found 
that vimentin can be secreted [31, 32]. On the other hand, 
desmin has been found to be present in human plasma 
[33], though no specific cell type has been reported to be 
responsible for its secretion. However, increased levels 
of desmin in tumor stroma have been related to advanced 
stages of colorectal cancer [34]. Nevertheless, there could 
be an alternative explanation for the presence of classic 
cytoskeleton proteins in the CMs. We hypothesize that 
hATT-CMs could have increased levels of exosomes, 
which are cell-derived extracellular vesicles that play an 
important role in cell-cell communication [35]. They can 
transfer genetic material, proteins and lipids from one cell 







Score in the canonical axis of each hATN-CM from the discriminant analysis (Figure 3C) correlated with body mass index 
(BMI). Nonparametric Spearman correlation test was performed between score and BMI. Correlation was significant 
(p<0.05). A more positive score represents a hATN sample more different from the hATT group. As the score approaches to 
0, the hATN-CM sample is more similar to the hATT-CMs group and, at the same time, the BMI of that women increase.
Table 1: Correlation of hATT-CMs score with tumor stage and histological grade
hATT-CM Score Stage HG
“25” -2.69 IIb HG3
“20” -1.47 IIa HG3
“22” -1.31 I HG2
“30” -1.17 I HG2
“19” -1.17 I HG2
“27” -0.44 I HG1
Score in the canonical axis of each hATT-CM from the discriminant analysis (Figure 3C) correlated with tumor stage and 
histological grade (HG). Nonparametric Spearman correlation test was performed between score and tumor stage and 
between score and HG. In both cases, correlation was significant (p<0.05). A more negative score represents a hATT sample 
more different from the hATN group. Thus, the sample with a score closer to 0 (“27”) is the most similar within the hATT-
CM to a hATN-CM and this goes in line with the lower tumor stage and HG of the tumor from that patient.
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to another [36]. In this regard, cytoskeleton proteins are 
often found in exosomes. Furthermore, in our proteomics 
analysis we found that hATT-CMs present a number of 
histones (Supplementary Table 1), which are usually found 
in an extracellular localization as components of exosomes 
[37, 38]. Though more evidence is necessary to validate 
this hypothesis, our results could be indicating that a 
specific type of communication occurs between adipose 
tissue from tumor microenvironment and tumor cells.
Therefore, the comparative analysis of the secretion 
profiles of hATT and hATN, by means of 2D-nanoLC-
MS/MS, indicated that the adipose tissue from tumor 
microenvironments presented a “reactive” state, and that 
this adipose tissue secretes increased levels of proteins 
involved in immunological, metabolic and angiogenic 
processes, resulting in the promotion of tumor progression.
To further extend the proteomics characterization 
of the CMs and to identify those proteins that are 
relevant as components of a tumor or normal breast 
microenvironment, we used an array against 42 human 
cytokines (Figure 3). On the one hand, the similarity 
between the expression profiles (IL6, IL8, MCP-1, GRO 
and angiogenin) of hATT-CMs and hATN-CMs denotes 
the likeness in the origin of the obtained adipose tissues. 
If the cell composition of hATT and hATN had been 
significantly different, we would have expected greater 
differences in the cytokine profiles obtained. When we 
compared differences in the levels of these cytokines, 
and others less expressed, we did not find a significant 
difference between the hATN-CMs and hATT-CMs. As 
stated before, the lack of significant difference could be 
due to the fact that too many variables (cytokines) are 
being tested at the same time, and/or because the number 
of samples of each group is too small. However, we did 
find a tendency in some cases. In particular, IL-6 seemed 
to be increased in hATT-CMs compared to hATN-CMs. 
Several works have described that stromal IL-6 secreted 
by adipose cells can increase cell migration, invasion 
and tumor growth [39, 40, 41]. Dirat et al. found that 
cancer-associated adipocytes (CAAs) secrete IL-6 in vitro 
and, using human tissue samples, they showed that this 
interleukin is increased in tumor stroma, specifically in 
CAAs [42].
Surprisingly, we found a decrease of MCP-1 and 
MCP-2 in hATT-CMs compared to hATN-CMs. These 
two cytokines are involved in macrophage recruitment, 
and have been previously found to be increased in breast 
tumors [43, 44]. Furthermore, it has been described 
that MCP-1 stromal levels correlate with the number of 
tumor-associated macrophages (TAMs), in a xenographic 
model of breast cancer [45]. Nevertheless, in the above 
mentioned work the cellular origin of MCP-1 was not 
clear, since the authors only distinguished tumor cells 
from stromal cells, and did not identify which stromal cell 
type was releasing MCP-1. Therefore, it is possible that 
our results indicate that adipose tissue is not involved in 
the release of these cytokines into the tumor stroma.
Since most of the cytokines evaluated in this 
array can have redundant, synergistic and/or opposite 
effects, we then evaluated if the levels of some of these 
proteins taken together could be relevant as differential 
components of hATT-CMs and hATN-CMs. To test this 
idea, we performed a multivariate discriminant analysis 
considering the 7 cytokines detected. The results from the 
discriminant analysis allowed us to identify IL6, GRO 
and MCP-2 as sufficient and necessary to differentiate 
hATT-CMs from hATN-CMs (Figure 3C). In addition, we 
found that in the case of the hATT-CMs the levels of these 
three cytokines taken together, represented by the score, 
correlated with stage and histological grade of the tumor 
(Table 1). This was a surprising result since what we are 
comparing are the levels of these cytokines secreted by the 
adipose tissue from the tumor microenvironment with the 
stage and differentiation state of the tumor. Moreover, in 
the hATN-CMs group we found that the score correlated 
with the BMI of the women (Table 2). This means that the 
sample from the woman with the higher BMI is the one, 
among the hATN-CMs group, more similar to a hATT-CM 
at least in regards to the secretion of the three cytokines. 
The implication of this result is that the human breast 
adipose tissue from a healthy overweight woman seems to 
be behaving more similarly to the human breast adipose 
tissue from a tumor microenvironment.
In our experimental model we employed whole 
tissue explants and did not isolate specific cell types. 
Therefore, although our explants came from breast adipose 
tissue, there are other cell types present apart from adipose 
cells (e.g. macrophages, fibroblasts, endothelial cells and 
immune cells). Nevertheless, adipose cells (preadipocytes, 
adipocytes and CAAs) are by far the predominant cell 
type in the explants. This was confirmed analyzing the 
histology of the explants [18]. In addition, the secretion 
profiles found for hATT and hATN agreed with secretomes 
from adipose tissue and adipocytes described by other 
groups [20, 30].
Our results raise some intriguing questions about 
the adipose tumor microenvironment. For instance, we 
wonder if there could be a potential prognostic value of 
the cytokines IL-6, GRO and MCP-2 or if they could 
be used as additional markers for breast tumor stage. Of 
course, further and extensive analyses are required to 
confirm these results, starting by increasing the number 
of samples being tested, and also quantifying the actual 
concentration of the cytokines by ELISA.
The identification of these factors, both in normal 
and tumor adipose tissue, and the study of their possible 
involvement in the regulation of tumor progression, might 




Reagents were purchased from Sigma Chemical Co 
(St. Louis, MO, USA), tissue culture flasks and dishes 
were from Falcon Orange Scientific (Graignette Business 
Park, Belgium) and NEST Biotechnology (Wuxi, China), 
culture media and supplements were from Gibco BRL 
(Carlsbad, CA, USA).
Sample collection and handling
We collected samples of human breast adipose 
tissue from both tumor (hATT, n=13) and normal breasts 
(hATN, n=8). hATT tissue samples were obtained 
from estrogen and/or progesterone receptor positive, 
infiltrating ductal carcinomas. None of the patients had 
received chemotherapy or radiotherapy treatment. The 
surgeon removed fragments of adipose tissue located 
approximately 2 cm from the tumor. hATN tissue samples 
were obtained from plastic surgeries performed for 
aesthetic reasons (breast reduction). All samples were 
processed within 2 h under a sterile laminar flow hood. 
At arrival, tissues were transferred to a Petri dish. If the 
explants had high and visible amounts of connective 
tissue and vessels, they were cut-off from the tissue 
explants. Then, tissues were extensively washed 3 times 
with ice PBS supplemented with gentamicin (50 μg/
ml). The samples were weighed and placed in a culture 
flask with M199 culture medium (Invitrogen™) (1g 
tissue/10 mL M199) supplemented with gentamicin (50 
μg/mL) and incubated for 1 h at 37°C in 5% CO2. After 
this time, medium was removed and replaced with fresh 
medium and put back in the incubator. After 24 h CM 
was collected, centrifuged, filtered, aliquoted into 1 mL 
fractions and immediately stored at -20°C, until used. 
M199 medium was used as control-CM. All patients gave 
their written consent. Samples (tumor and normal) were 
collected following the approval of the Ethics Committee 
of both the IBYME and the Complejo Médico Policial 
“Churruca-Visca”.
Polyacrylamide gel electrophoresis
100 μL of hATT-CMs (n=7) and hATN-CMs (n=3) 
were loaded onto a 10% SDS-PAGE gel, and proteins 
were separated by electrophoresis, at a constant voltage 
of 100 V. After the run, the gel was fixed with a 50% 
v/v ethanol, 2% v/v phosphoric acid solution, overnight 
at 4°C. Then, gel was washed 3 times and proteins 
were dyed with Coomassie Blue G250 solution (Sigma 
Chemical Co, St. Louis, MO, USA). Control-CM 
was used as control and a lane with molecular weight 
markers was included.
Protein identification by mass spectrometry 
analysis
Lyophilized aliquots (30 μg) of hATT- (n=6) and 
hATN-CMs (n=3) were resuspended in low salt buffer 
(10 mM HEPES pH7.9, 10 mM KCl, 1.5 mM MgCl2) for 
15 min on ice and then homogenized using a motorized 
pestle. The lysate was centrifuged at 4°C at 800xg. 
The proteins obtained were reduced with 50 mM DTT 
(Sigma Aldrich, Saint Louis, MO) at 65°C for 5 min, 
alkylated with 100 mM iodoacetamide (Sigma Aldrich), 
and digested using sequencing grade trypsin (Promega, 
Madison, WI) overnight at 37°C. The digestion was 
stopped by the addition of 0.5% acetic acid, frozen in dry 
ice, and concentrated using a Savant SpeedVac centrifuge 
(Thermo Scientific, Hudson, NH). The tryptic-digested 
peptides were dissolved in 100 mM ammonium formate 
pH10 and separated through 2D-nanoLC with dilution 
using a 2D-nanoAcquity UPLC (Waters Corporation, 
Milford, MA). The first dimension was performed in 
XBridge BEH130 C18, 5μm, 300μm x 50 mm NanoEase 
Column (Waters Corporation, Milford, MA) using as 
solvent A1 20 mM ammonium formate pH10 and B1, 
100% acetonitrile (Optima LC/MS, Fisher Scientific, 
Pittsburgh, PA) LC-MS grade. The flow at 1st dimension 
was 2uL/min, and 11 different step gradients (dilution 
method) were performed for 20 min each. The second 
dimension included trapping and desalting online through 
180μm x 20 mm, 5μm symmetry C18 nanoAcquity UPLC 
trap column (Waters) at a flow 20 uL/min, 99% A2 (water, 
0.1% formic Acid), and 1% B2 (100% acetonitrile, 0.1% 
formic acid) for 20 min. After the peptides were desalted 
and concentrated, they were separated online in the second 
dimension through BEH130 C18 1.7 μm, 100 μm x 100 
mm nanoAcquity UPLC column. The standard solvent 
gradient used was: 0-2 min, 3% B2 isocratic; 2-40 min, 
3-85% B2 linear, at a flow rate of 400 nL/min for 60 min. 
The eluted ions were analyzed by one full precursor MS 
scan (400to1500 m/z) followed by four MS/MS scans 
of the most abundant ions detected in the precursor MS 
scan while operating under dynamic exclusion or direct 
data acquisition system (DDAS). Spectra obtained in the 
positive ion mode with nano ESI-QTof Synapt G1 mass 
spectrometer (Waters) were deconvoluted and analyzed 
using the MassLynx software 4.1 (Waters). A peak list 
(PKL format) was generated to identify 1 or multiple 
charged precursor ions from the mass spectrometry data 
file. The instrument was calibrated in MS/MS mode using 
100 fmol of (Glu1)-Fibrinopeptide B human (Sigma) with 
a RMS residual of 3.857 e4 or 6.9413 e-1 ppm or 7.722 
e0 ppm. Parent mass (MS) and fragment mass (MS/
MS) peak ranges were 400-1500 Da and 65-1500 Da 
respectively. Mascot server v2.5.0 and Mascot Daemon 
Toolbox v2.5.1 (www.matrix-science.com, UK) in MS/MS 
ion search mode (local licenses) were applied to conduct 
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peptide matches (peptide masses and sequence tags) and 
protein searches against NCBInr v20150531 (67337701 
sequences, 24122812982 residues) taxonomy filter 
(Homo sapiens) (311623 sequences) and IPI Human v3.80 
(86719 sequences, 34928216 residues). The following 
parameters were set for the search: carbamidomethyl 
(C) on cysteine was set as fixed; variable modifications 
included asparagine and glutamine deamidation and 
methionine oxidation. One missed cleavage was allowed; 
monoisotopic masses were counted; the precursor peptide 
mass tolerance was set at 50 ppm; fragment mass tolerance 
was 0.3 Da, and the ion score or expected cut-off was set at 
5. The MS/MS spectra were searched with MASCOT using 
a 95% confidence interval (C.I. %) threshold (p < 0.05). A 
minimum score of 46 was used for peptide identification. 
The protein redundancy that appeared at the database 
under different gi (protein accession number) was limited 
to human with the first priority assigned to that species. 
Data was analyzed using ProteoIQ (Premier Biosoft) and 
FunRich version 3 software [46]. These software allows to 
visualize GO and pathways in the generated data.
Cytokine antibody array
To detect and compare the level of 42 specific 
cytokines we used a Human Cytokine Antibody Array 
(Abcam #133997). Experiments were performed following 
the manufacturer´s protocol. 1 mL of each hATT-CMs 
(n=6), hATN-CMs (n=3) or control-CM was used to 
incubated individual membranes. Spots were visualized by 
means of chemiluminescence and quantified using ImageJ 
software available at the NIH site [47]. Dots on each 
membrane were relativized to positive control spots on the 
same membrane and normalized to control-CM membrane.
Statistical analysis
For univariate analysis of cytokines from the array, 
the statistical significance was evaluated by Student´s t-
test with Bonferroni correction. Results are presented 
as mean ± SEM. Results were considered significant at 
p < 0.05, using GraphPad Prism® version 5.01 software 
(GraphPad Software Inc., CA). Multivariate analysis and 
nonparametric Spearman correlation test were performed 
with InfoStat version 2014 [48].
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